>>Signaling Pathways>> GPCR/G protein>> Neuropeptide FF/AF Receptors>>Neuropeptide Y (human,rat,mouse) (TFA)

Neuropeptide Y (human,rat,mouse) (TFA)

Catalog No.GC72092

Neuropeptide Y (human,rat,mouse) (TFA)알츠하이머병(AD)에 참여하여 베타-아밀로이드 독성으로부터 쥐의 피질 뉴런을 보호합니다.

Products are for research use only. Not for human use. We do not sell to patients.

Neuropeptide Y (human,rat,mouse) (TFA) Chemical Structure

Size 가격 재고 수량
1 mg
US$88.00
재고 있음
5 mg
US$198.00
재고 있음
10 mg
US$307.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com


고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents
Neuropeptide Y (human) TFA is involved in Alzheimer's disease (AD) and protects rat cortical neurons against β-Amyloid toxicity.

It is showed that Neuropeptide Y (human) is able to protect cortical neurons from Aβ25-35 toxicity. 2 μM NPY abolishes the toxic effects of Aβ25-35 at 24 and 48 h. The same effect on neuronal survival is observed in neurons exposed to 1 μM and 0.5 μM Neuropeptide Y (human) pretreatments. Pretreatment with Neuropeptide Y (29-64), amide, human (TFA) Increases NGF Synthesis, reduces NGF mRNA, and restores NGF release in cortical neurons exposed to Aβ35-25[1].

References:
[1]. Croce N, et al. Neuropeptide Y protects rat cortical neurons against β-amyloid toxicity and re-establishes synthesis and release of nerve growth factor. ACS Chem Neurosci. 2012 Apr 18;3(4):312-8.

리뷰

Review for Neuropeptide Y (human,rat,mouse) (TFA)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Neuropeptide Y (human,rat,mouse) (TFA)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.